Patient Controlled Injectors Market Growth Report | 2021 to 2031
The Patient controlled injectors market size in 2021 stood at US$ 3.71 billion and is projected to reach US$ 12.33 billion by 2031 from US$ XX billion in 2023. The market is expected to register a CAGR of 12.9% in 2023–2031. Technology advancements in wearable injectors, such as bluetooth integrated wearable injectors, enable the transmission of signals to patients, such as injection reminders, and provide patients with access to therapy data are likely to remain key Patient Controlled Injectors Market trends.
Patient Controlled Injectors Market Analysis
The rising prevalence of chronic ailments such as diabetes, rheumatoid arthritis, and autoimmune diseases contributes to the demand for patient-controlled injectors. These devices offer comfort and ease of use to patients who require frequent disease control injections. Patient Controlled Injectors Market enable patients to self-administer medication at home, decreasing the need for frequent hospital visits and increasing patient convenience.
Patient Controlled Injectors Market Overview
The demand for patient-controlled injectors went up during the pandemic. Factors such as expanding patient population, a shortage of healthcare resources, and ease of increased the adoption of injectors had positive impact on the market by certain extent. However, the introduction of physical distance policies and firm closures to prevent viral infection disrupted supply chain processes, negatively impacting market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Patient Controlled Injectors Market: Strategic Insights
Market Size Value in US$ 2,969.47 Million in 2019 Market Size Value by US$ 7,505.70 Million by 2027 Growth rate CAGR of 12.4% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Patient Controlled Injectors Market: Strategic Insights
| Market Size Value in | US$ 2,969.47 Million in 2019 |
| Market Size Value by | US$ 7,505.70 Million by 2027 |
| Growth rate | CAGR of 12.4% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Patient Controlled Injectors Market Drivers and Opportunities
Rising Patient Compliance to Favor the Market Growth
Patient-controlled injectors are expected to rise concurrently in the market owing to greater ease, safety, and comfort of the administration of injections, which is likely to gain significant popularity among patients. In addition to this, the controlled release of the patient-controlled injectors helps the patient administer the drug by themselves and decide their dosage rate.
Besides this, it is crucial to ensure the safety of healthcare providers. According to an article published by NIH in 2023, In developing countries, 40-65% of hepatitis B infections in healthcare workers were attributable to percutaneous occupational exposure. Many manufacturers are now focusing on developing patient-controlled injectors to meet the unmet needs, which, in turn, is stimulating the growth of the market.
Adoption of Self-Administered Medication
Patients use self-administered medication to control blood pressure, blood glucose, and other chronic illnesses. Self-medication refers to the use of medicinal items by consumers to treat self-diagnosed disorders or symptoms, as well as the intermittent or continuous use of medication recommended by a physician for chronic or recurring diseases or symptoms. Chronic diseases require repeated dosing, therefore these indications represent large drug volume and revenue opportunities. According to a study published in the Lancet in June 2023, the number of individuals with diabetes globally is expected to reach 1.3 billion by 2050. Diabetes self-management is the technique of determining and giving insulin doses based on self-measured capillary glucose readings. self-administered medication foe diabetes is giving insulin doses based on self-measured capillary glucose readings.
Patient Controlled Injectors Market Report Segmentation Analysis
Key segments that contributed to the derivation of the Patient Controlled Injectors Market analysis are product, application, and distribution channel.
- Based on product, the Patient Controlled Injectors Market is divided into electronic wearable injectors, mechanical wearable injectors, and infusion pumps. The electronic wearable injectors segment held a larger market share in 2023.
- By cause, the market is segmented into cancer treatment, auto-immune treatment, blood disorders treatment, and others. The cancer treatment segment held the largest share of the market in 2023.
- In terms of category, the market is segmented into hospital pharmacies, retail pharmacies, and mail order pharmacies. The hospital pharmacies segment dominated the market in 2023.
Patient Controlled Injectors Market Share Analysis by Geography
The geographic scope of the Patient Controlled Injectors Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the Patient Controlled Injectors Market. The growth of the North American market is characterized by the rising prevalence of chronic diseases like cancer, autoimmune disease, cardiovascular diseases and others, along with development of innovative products and presence of key market players in the region. In addition, technological advancements for the treatment of diseases is likely to be a major growth stimulator for the Patient Controlled Injectors Market market in the region.
Patient Controlled Injectors Market Report Scope
Patient Controlled Injectors Market News and Recent Developments
The Patient Controlled Injectors Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for Patient Controlled Injectors Market:
- Ypsomed (SIX: YPSN) has developed a new autoinjector platform for liquid medications with volumes ranging from 1.5 to 5.5 ml. The YpsoMate 5.5 is the latest addition to the growing YpsoMate family of devices and is based on the established technology of the YpsoMate 2.25 Pro. YpsoMate 5.5 enables the self-administration of larger volume medications for treating cancer, rare and autoimmune diseases. (Source: Ypsomed AG, Press Release, 2022)
- Gerresheimer acquired the IP of a new generation cartridge based autoinjector from Midas Pharma. This is the start of a strategic partnership. The joint project comprises the development and marketing of the new generation autoinjector. (Source: Gerresheimer AG, Press Release, 2021)
Patient Controlled Injectors Market Report Coverage and Deliverables
The “Patient Controlled Injectors Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Market dynamics such as drivers, restraints, and key opportunities
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product ; Application ; Distribution Channel , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For